Arovella Therapeutics (ALA) EGM 2025 summary

Opening remarks and agenda

• Meeting opened at 11:00 A.M. with a quorum present and proper constitution confirmed.

• Directors and Company Secretary introduced; apology noted for one absent director.

• Meeting held virtually, enabling live participation, Q&A, and voting.

Specific resolutions to be voted on

• Resolution One: Ratification of the issue of placement shares from March 2025 placement.

• Resolution Two: Ratification of placement options from March 2025 placement.

• Proxy results for both resolutions displayed and determined by poll.

Q&A with stakeholders

• Shareholders could submit questions via the online platform, with instructions provided.

• Questions addressed included webcast availability and future meeting formats.

• Confirmation given that webcasts are posted on the investor website.

• Explanation provided for virtual format due to director locations; future meetings planned as hybrid or in-person.